Pioneering the technologies for generative protein design at the intersection of synthetic biology and AI.
Biomatter Designs has raised €500k across 1 funding round from 1 investor, most recently a round in Jan 2021. Based in Vilnius, Austria; founded 2018; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-01-11 | Other | €500k |
| Practica Capital |
| View deal → |
